Malaria vaccine trials: The missing qualitative data

Immunology and Cell Biology

Volumn 74, Issue 4, 1996, Pages 301-305

  Ferreira, M U ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antibody affinity; IgG subclasses; Malaria vaccines; Plasmodium falciparum

Indexed keywords

IMMUNOGLOBULIN G; MALARIA VACCINE;

ANTIBODY RESPONSE; HUMAN; IMMUNIZATION; IMMUNOGENICITY; MALARIA; SHORT SURVEY;

PLASMODIUM FALCIPARUM;

EID: 0029765765     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1038/icb.1996.54     Document Type: Short Survey

References (20)

1. Valero MV, Amador LR, Gallindo C et al. Vaccination with SPf66, a chemically synthesised malaria vaccine, against Plasmodium falciparum malaria in Colombia. Lancet 1993; 341: 705-10.
2. Alonso PL, Smith T, Armstrong-Schellenberg JRM et al. Randomized trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania. Lancet 1994; 344: 1175-81.
3. D'Alessandro U, Leach A, Drakeley CJ et al. Efficacy trial of malaria vaccine SPf66 in Gambian infants. Lancet 1995; 346: 462-7.
4. Salcedo M, Barreto L, Rojas M, Moya R, Cote J, Patarroyo ME. Studies on the humoral immune response to a synthetic vaccine against Plasmodium falciparum malaria. Clin. Exp. Immunol. 1991; 84: 122-8.
5. Amador R, Moreno A, Murillo LA et al. Safety and immunogenicity of the synthetic malaria vaccine SPf66 in a large field trial. J. Infect. Dis. 1992; 166: 139-44.
6. Leach A, Drakeley, CJ, D'Alessandro U et al. A pilot safety and immunogenicity study of the malaria vaccine SPf66 in Gambian infants. Parasite Immunol. 1995; 17: 441-4.
7. Patarroyo ME, Vinasco J, Amador R et al. Genetic control of the immune response to a synthetic vacine against Plasmodium falciparum. Parasite Immunol. 1991; 13: 509-16.
8. Rocha CL, Murillo LA, Mora AL et al. Determination of the immunisation schedule for field trials with the synthetic malaria vaccine SPf66. Parasite Immunol. 1992; 14: 95-109.
9. Noya O, Berti VG, de Noya BA et al. A population-based clinical trial with the SPf66 synthetic Plasmodium falciparum malaria vaccine in Venezuela. J. Infect. Dis. 1994; 170: 396-402.
10. Erunkulu OA, Hill AV S, Kwiatkowski DP et al. Severe malaria in Gambian children is not due to lack of previous exposure to malaria. Clin. Exp. Immunol. 1992; 89: 296-300.
11. Bouharoun-Tayoun H, Attanath P, Sabchareon A, Chongsuphajaisiddhi T, Druilhe P. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth in vitro but act in cooperation with monocytes. J. Exp. Med. 1990; 172: 1633-41.
12. Bouharoun-Tayoun H, Druilhe P. Plasmodium falciparum malaria: Evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity. Infect. Immun. 1992; 60: 1473-81.
13. Chappel JA, Egan AF, Riley EM, Druilhe P, Holder AA. Naturally acquired human antibodies which recognize the first Epidermal Growth Factor-like module in the Plasmodium falciparum Merozoite Surface Protein 1 do not inhibit parasite growth in vitro. Infect. Immun. 1994; 62: 4488-94.
14. Groux H, Gysin J. Opsonisation as an effector mechanism in human protection against blood stages of Plasmodium falciparum: Functional role of IgG subclasses. Res. Immunol. 1990; 141: 529-42.
15. Bouharoun-Tayoun H, Oeuvray C, Lunel F, Druilhe P. Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages. J. Exp. Med. 1995; 182: 409-18.
16. Ferreira MU, Kimura EAS, Souza JM, Katzin AM. The isotype composition and avidity of naturally acquired anti-Plasmodium falciparum antibodies: Differential patterns in clinically immune Africans and Amazonian patients. Am. J. Trop. Med. Hyg. 1996 (in press).
17. Steward MW. The biological significance of antibody affinity. Immunol. Today 1981; 2: 134-40.
18. Kenney JS, Hughes BW, Masada MD, Allison AC. Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies. J. Immunol. Methods 1989; 121: 157-66.
19. Granoff DM, Lucas AH. Laboratory correlates of protection against Haemophilus influenzae type b disease. Importance of assessment of antibody avidity and immunologic memory. Ann. N.Y. Acad. Sci. 1995; 754: 278-88.
20. Ferreira MU, Katzin AM. The assessment of antibody affinity distribution by thiocyanate elution: A simple dose-response approach. J. Immunol. Methods 1995; 187: 297-305.